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Abstract Stimulation of DNA and protein synthesis in brown 
preadipocytes by 1 |iM neokyotorphin in serum-containing media 
was comparable with the effect of 1 jiM norepinephrine. In 
serum-free medium a decrease and a shift of the maximal effect 
to lower concentration of neokyotorphin were observed. Kyotor-
phin had no effect on cell proliferation in either medium; 
however, 0.01-1 JIM kyotorphin inhibited the cell proliferation 
stimulated by 1 uM norepinephrine. Norepinephrine and both 
peptides stimulated comparable Ca2+ rise in freshly isolated 
brown preadipocytes. The effects of neokyotorphin and norepi-
nephrine were additive, whereas 0.03-0.3 (iM kyotorphin blocked 
the action of 3 (iM norepinephrine. The peptides did not affect 
the cAMP level in non-stimulated or norepinephrine-stimulated 
cultured cells. The effects of the peptides on the brown fat cell 
cultures indicate that peripheral tissue cells contain receptors for 
these neuropeptides. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Brown adipose tissue constitutes an interesting model for 
studies of cell proliferation and cellular differentiation. Brown 
adipose tissue plays a major role in production of heat neces-
sary for newborns, hibernators and mammals living in the 
cold. In brown adipose tissue both the facultative thermogenic 
response and the long-term recruitment processes in the tissue 
are under positive adrenergic control. Cold exposure of an 
animal induces within the tissue a marked increase in mito-
genic activity and in the expression of genes coding for pro-
teins specific for brown adipose tissue function. Norepineph-
rine, released from sympathetic nerve fibres in the tissue, acts 
through ß-adrenergic receptors and elevation of intracellular 
cAMP [1,2]. An interesting point is that although the physio-
logical stimulus for recruitment remains switched on, the cells 
only respond with a limited and well-controlled hyperplasia. 
The regulatory factors behind the limited hyperplasia are still 
not defined. 
A study of the regulatory factors behind the large-scale 
physiological changes in hibernating and cold-acclimated ani-
mals can help to clarify molecular events leading to many 
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pathological processes in normothermic mammals. During 
the last years, several peptides possibly involved in regulation 
of hibernation have been isolated from the brain of hibernat-
ing ground squirrels [3-5]. It was found that two of them, 
which turned out to be the already known neuropeptides kyo-
torphin (Tyr-Arg, YR) and neokyotorphin (Thr-Ser-Lys-
Tyr-Arg, TSKYR), had some thermoregulatory properties 
when intraperitoneally injected into animals [5,6]. Kyotorphin 
and neokyotorphin are related to 'non-classical' 'opioid-like' 
peptides and may be involved in pain regulation in mammals 
[7], but they do not bind to typical opioid receptors [8]. Kyo-
torphin induces analgesia by a release of Met-enkephalin in 
the brain [8,9] and neokyotorphin by an inhibition of a stimu-
lated release of y-aminobutyric acid [10]. 
Using a brown fat cell culture system, we have studied the 
ability of kyotorphin and neokyotorphin to affect cell culture 
growth and to modulate the adrenergic stimulation of cell 
proliferation. We proposed that outside the central nervous 
system, these peptides may not have an analgesic, but rather 
another function, such as regulation of mitogenic activity. In 
order to analyse the effect of the peptides in the absence of 
'classical' growth factors, a system for the culture of brown 
fat cells under fully defined conditions has been developed 
[11]. Preliminary results were reported earlier [12,13]. 
2. Methods 
2.1. Cell isolation and cultivation 
Brown fat precursor cells were isolated from 3^4-week-old male 
mice of the NMRI strain principally as described earlier [1]. The 
brown adipose tissue depots were dissected out from each mouse, 
and the tissue was digested with crude collagenase type 2 (200 U/ 
ml). The infranatant was filtered and the precursor cells were pelleted 
by centrifugation, suspended in culture medium and inoculated onto 
6- or 12-well standard plates (density 90 000 cells/cm2). The cells were 
cultivated in a culture medium consisting of Dulbecco's modified Ea-
gle's medium (DMEM) supplemented with 10% new-born calf serum 
and insulin. For experiments in serum-free conditions, standard me-
dium was changed on day 3 or 4 to a DMEM/F12-based serum-free 
medium, supplemented with 0.5% albumin [11]. 
The experiments were performed with cells grown in culture for 3-4 
days with serum or for 5 days with 1-2 days without serum, i.e. 
preconfluent, proliferating cells. Peptides were added 5 min before 
norepinephrine. Incubation with peptides, 1 uM norepinephrine and 
[3H]thymidine was terminated by harvesting the cells 4 h (with serum) 
or 20 h (serum-free medium) after addition of agents. A cell homo-
genate was prepared and used for protein, DNA and [3H]thymidine 
determination as described earlier [1]. 
2.2. cAMP determination 
The cultured cells were incubated for 5-10 min (day 3^1) or 20-30 
min (day 6) with the agents, the medium was discarded and ethanol 
was added to each well for cAMP extraction. The samples were dried 
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in a Speedvac centrifuge and cAMP was analysed according to the 
description in the Cyclic AMP [3H] Assay System from Amersham. 
2.3. IP% determination 
The cultured cells were incubated for 0.5-20 min with 1 uM agents, 
the medium was discarded and 0.6 ml of 0.5 M HCIO4 was added to 
each well and the cells were harvested. The suspension was centrifuged 
(16000XgXlO min) and to 0.5 ml of supernatant 50 ul of 2.5 M 
K 2 C0 3 in 60 mM HEPES buffer was added. After 20 min incubation 
and centrifugation (16000XgX3 min), 100 (xlx2 aliquots were used 
for IP3 determination in the D-myo-inositol-l,4,5-triphosphate [3H] 
Assay System from Amersham. 
2.4. Measurement of intracellular Ca2+ 
Concentration of Ca2+ in cultured cells was measured as described 
earlier [14] using the fluorescent dye Fura-2. Cells were grown on 
coverslips in 6-well plates. On the day of the experiment cover-slips 
were transferred to Krebs-Ringer phosphate buffer and cells were 
loaded with Fura-2 for 1 h. Fluorescence was measured in Krebs-
Ringer bicarbonate buffer with excitation wavelengths of 355 and 
395 nm. Ionomycin (30 uM) and 2 mM MnCl2 were used to estimate 
_Rmax and i?min, respectively. 
Freshly isolated brown preadipocytes were loaded with Fura-2, and 
the fluorescence was measured in Hanks' balanced salt medium, buf-
fered with 10 mM HEPES, pH 7.2. Fmax was estimated by adding 25 
uM digitonin; F^B = FmBxl3. The wavelengths of excitation and regis-
tration were 337 nm and 495 nm, respectively. 
2.5. Receptor binding experiments 
Membranes from brown adipose tissue depots were prepared as 
described earlier [15]. Competition-binding experiments were per-
formed with 0.8 nM [3H]Prazosin and [3H]CGP-12177, and 
5 x l 0 _ 9 - 1 0 - 3 M kyotorphin and neokyotorphin. Non-specific bind-
ing was measured in the presence of 5000-fold excess of phentolamine 
and alprenolol, respectively. 
3. Results and discussion 
The presented results indicate that the investigated neuro-
peptides act in opposite directions on the proliferation of cul-
tured brown preadipocytes. A pronounced stimulation of 
brown preadipocyte proliferation by neokyotorphin was ob-
tained in the presence of new-born calf serum (Fig. 1A). The 
effect of neokyotorphin was comparable with the effect of 
norepinephrine, but their actions were not additive: neokyo-
torphin had only a small additional effect in the presence of 
norepinephrine. The effect of neokyotorphin was clearly dose-
dependent, EC5o~0.6 uM. In serum-free conditions, the effi-
ciency of neokyotorphin was higher, its dose response curve 
had a bell-shape in the range 1-100 nM (not shown). Under 
these conditions both norepinephrine (it was also shown ear-
lier [11]) and neokyotorphin, had smaller effects (Fig. IB), 
although the additivity was more pronounced. The shorter 
peptide, kyotorphin, had in itself very low inhibitory or no 
effect on cell proliferation, whereas kyotorphin at some con-
centrations abolished the simulatory effect of norepinephrine 
on cell proliferation (Fig. 1C,D). In the presence of serum, the 
most effective concentration of kyotorphin was around 1 U.M, 
whereas in serum-free medium the effect was shifted to lower 
concentrations of the peptide, ICso~3 nM (Fig. ID). In con-
trast to norepinephrine [1] neither peptide affected the specific 
labelling of DNA with [3H]thymidine. 
In competition-binding experiments, we checked a possible 
binding of the peptides to ßi- and ai-adrenoceptors and did 
not find any interaction (not shown). There is little evidence in 
the literature for the existence of specific receptors for these 
peptides. The kyotorphin receptor has been identified in mem-
branes of rat brain. The low-affinity receptor appears to be 
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functionally coupled via G; to stimulation of phospholipase C 
and an increase in IP3 [16-18]. A receptor and a second mes-
senger for neokyotorphin have not been identified. With a 
commercially available [3H] assay kit for IP3, we were only 
able to reliably register the effect of norepinephrine on differ-
entiated brown adipocytes (day 6 in culture). All changes in 
IP3 after addition of norepinephrine to proliferating cells were 
on the limit of the sensitivity of the kit. For 1 u.M peptides we 
were unable to find any signs of their action, neither in pro-
liferating nor in differentiated cells. This is not contradictory 
to the results published in [16] because they found a statisti-
cally significant accumulation of IP3 only with 100 \iM kyo-
torphin. 
Measurements of intracellular Ca2+ in cultured cells were 
carried out with cells grown on cover-slips. Due to the low 
number of the cells and, therefore, low signal/noise ratio, we 
could not work with the cells in the early stages of prolifer-
ation but used them on day 4, when up to 30% of the cell 
population showed characteristics of differentiation. To ex-
clude an effect of the peptides on the differentiated cells, we 
compared proliferating cells with differentiated cultured 
brown adipocytes and freshly isolated preadipocytes. 
Principal difference in the kinetics and magnitude of Ca2+ 
response has been found between the freshly isolated and the 
cultured cells. The effect of norepinephrine on cultured cells 
was quick and high in magnitude (ti/2 ~ 0.2 min, 
A[Ca2+]i ~ 300-800 nM, Fig. 2A) both in proliferating and 
differentiated cells. As a first approximation, 0.3-30 uM neo-
kyotorphin approximately doubled [Ca2+]i in the cells; this is 
in agreement with the effect of neokyotorphin on myocardial 
cells [3]. In the differentiated cells we did not find significant 
effects of neokyotorphin on [Ca2+];. Kyotorphin did not have 
any clear effect on [Ca2+]i in either cultured cells. The freshly 
isolated preadipocytes responded to norepinephrine very 
slowly (A[Ca2+]i~2 nM/min, Fig. 2B), all in accordance 
with the results of Tuchiya and Nagai [19]. Under these con-
ditions, norepinephrine and both peptides had almost identi-
cal kinetics of Ca2+ increase. Kyotorphin modulated the cel-
lular response to norepinephrine in either cells. It increased 
the magnitude of the stimulatory effect of norepinephrine on 
[Ca2+]i in cultured cells, but in freshly isolated cells kyotor-
phin at some concentrations blocked the stimulatory action of 
norepinephrine (Fig. 3). The most effective concentrations of 
kyotorphin in modulation of the Ca2+ response to norepi-
nephrine (0.03-0.3 U.M) were almost identical to those that 
were most effective in suppression of norepinephrine-induced 
cell proliferation (Fig. 1C,D). Neokyotorphin did not change 
the response of cultured cells to norepinephrine, but in freshly 
isolated cells there was seen a tendency to the additivity of 
their effects (Fig. 2B). 
The ability of adrenergic stimulation to affect the rate of 
DNA synthesis in mouse brown adipocyte precursor cells pro-
liferating in primary culture has earlier been investigated [1]. 
It was concluded that brown fat precursor cells respond di-
rectly to norepinephrine stimulation with an increased DNA 
and protein synthesis and that this response is mediated via 
the classical ßi receptors positively coupled to cAMP [1]. The 
investigated peptides did not in themselves affected cAMP 
accumulation, although 0.1-1 u\M kyotorphin influenced 
cAMP accumulation stimulated by norepinephrine, by ap-
proximately 20%. This either inhibitory or stimulatory effect 
was usually statistically significant within an experiment. Ear-
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Fig. 1. Effect of neokyotorphin (A,B) and kyotorphin (C,D) on DNA and protein synthesis in cultured preconfiuent proliferating brown adipo-
cytes, stimulated and non-stimulated with norepinephnne. Cells were cultivated in standard 6-well plates either in the presence of serum (A,C) 
or in serum-free conditions (B,D). Concentrations: 1 uM norepinephnne, 1 uM (A) and 0.01 (J.M (B) neokyotorphin, 1 uM kyotorphin (C). In 
each experiment, the average value obtained in the control non-treated wells was set to 100% and the data were expressed in percent of the 
control value. The mean value corresponding to 100% varied from an experiment to experiment within 2-5 |_ig DNA and 30-70 ug protein. 
Bars are means ± SE of all samples (4-7 experiments, 2-\ samples in each). The data were analysed for significant differences from their respec-
tive control values and, where relevant (YR+NE), from the NE effects in each experiment by Student's paired ï-test. M p < 0 . 1 ; *P<0.05; 
*WP<0.025; **P<0.01: *"/><0.001. 
lier we found that norepinephrine-stimulated DNA synthesis 
in proliferating cells is almost insensitive to these small varia-
tions in intracellular cAMP concentrations (G. Bronnikov et 
al., unpublished results). Therefore we conclude that the effect 
of kyotorphin on cAMP accumulation may be related to a 
'side effect' and can not explain the inhibitory action of the 
peptide. 
From our previous experiments, it is clear that cultured 
brown adipocytes contain Ca2+-activated adenylyl cyclase 
and phosphodiesterase [20], and a modulation of intracellular 
Ca2+ can affect these activities. In the differentiated cells, si-
multaneous activation of ß- and ai-receptors was shown to 
lead to two opposite effects. It increased 2-3-fold the expres-
sion of uncoupling protein mRNA with cAMP as second 
messenger, but at the same time the cti -mediated Ca2+ rise 
activated phosphodiesterase and therefore inhibited cAMP 
accumulation. The final effect depended on the relative acti-
vation of ß- and 04-receptors [20,21]. In proliferating cells, 
cAMP accumulation was almost insensitive to elevated 
Ca2+, and the Ca2+-ionophore, ionomycin (1 uM), had only 
a 10-15% inhibitory effect on cAMP level (80% in the differ-
entiated cells) [21]. Earlier it was found that in proliferating 
cells, norepinephnne utilises both ß- and oci -receptors syner-
gistically to maximally induce expression of the c-fos proto-
oncogene [14], but nothing is known about a role of Ca2+ in 
regulation of proliferation of brown adipocytes. The presented 
results are the first evidence of possible participation of Ca2+ 
ions in this regulation. 
The effects of the peptides on the brown adipocyte cell 
culture system clearly indicate that peripheral tissue cells con-
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tain receptors for these neuropeptides. We would like to spec-
ulate that outside the central nervous system these peptides do 
not have an analgesic, but another function: regulation of 
mitogenic activity in peripheral tissues. Most probably, the 
tissues of animals generally contain some amount of these 
peptides and enzymes for their formation and degradation. 
Alternatively neokyotorphin can also be produced by proteo-
lytic degradation of haemoglobin in erythrocytes [22]. The 
amino acid sequences of neokyotorphin and kyotorphin are 
identical to that of the five and two C-terminal amino acid 
residues of the haemoglobin A-chain, respectively. Brown adi-
pose tissue is highly enriched with blood vessels and capilla-
ries, and neokyotorphin originating from haemoglobin could 
play a role in brown adipose tissue recruitment under circum-
stances when the adrenergic system can not be used. The ratio 
of concentrations of these peptides may be an important pa-
rameter, because the stimulatory effect of neokyotorphin can 
be reversed by the cleavage of the peptide by a specific pro-
tease [23]. Very similar regulation was found for neokyotor-
phin recently [24]. Degradation of neokyotorphin of erythro-
cyte origin to neokyotorphin (1-4) resulted in formation of a 
novel activity: T S K Y induced D N A fragmentation in tumor 
cells [24]. 
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Fig. 2. Typical calcium response to norepinephrine and neokyotor-
phin in (A) 4-day cultured brown adipocytes and (B) freshly isolated 
brown preadipocytes. In (B) arrow indicates the additions: (o) con-
trol, ( A ) 3 uM TSKYR, ( A ) 3 uM NE, (•) NE+TSKYR. Data 
from four experiments were summarised (not shown) and analyzed 
by Student's paired Mest. The significant differences from the con-
trol for the effects of all agents and for the effect of TSKYR from 
NE+TSKYR are P < 0.025. 
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